Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
TG Therapeutics
3866
TG Therapeutics
Technology
Biotechnology
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies.
Suggest edits
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Bloomberg
Goldman Sachs
JPMorgan
Kickstarter
Wired
Morgan Stanley
The New York Times
Companies in the same industry
Sequenta
Northwest Biotherapeutics
Genentech
RetroSense
Aspire Bariatrics
Care Point Software
Bolt Threads
Synchro PET
Inspyr
Essia Health
Alexa global traffic share
Twitter followers
Overview
Add info
Team Size
10+
Employees
I work here
Location
New York
,
United States
Headquarters
Explore New York
MedCity News
FDA’s tighter scrutiny on drug class leads TG Therapeutics to pull out of cancer
the home of AI info
Reviewing Minerva Neurosciences Inc. (NERV)'s and TG Therapeutics Inc. (NASDAQ:TGTX)'s results
